These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6952656)

  • 1. [Labetalol in ambulatory therapy of hypertension].
    Zilcher H; Weber H; Glogar D
    Wien Med Wochenschr Suppl; 1981; 69():23-4. PubMed ID: 6952656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
    Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
    Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of treatment with labetalol on renal function in arterial hypertension secondary to parenchymal nephropathy and in essential arterial hypertension].
    Palla R; Bionda A; Carmassi F; Giusti R; Marchitiello M
    Recenti Prog Med; 1980 Nov; 69(5):551-5. PubMed ID: 7465989
    [No Abstract]   [Full Text] [Related]  

  • 4. [Labetalol in the treatment of resistant hypertension].
    Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
    Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L; Florio P; Guerrieri P; Lanciotti G; Mastrocola C; Petrosillo N; Scarfò G; Avella A
    Clin Ter; 1981 Oct; 99(2):139-47. PubMed ID: 7032831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ergometric control in hypertension treatment with labetalol].
    Prohaska H; Honetz N
    Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661
    [No Abstract]   [Full Text] [Related]  

  • 8. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute hemodynamic effect of labetalol in severe hypertension].
    Omvik P; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1980 Nov; 100(33):1971-4. PubMed ID: 7456057
    [No Abstract]   [Full Text] [Related]  

  • 10. Labetalol in the treatment of patients with hypertension and renal function impairment.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
    [No Abstract]   [Full Text] [Related]  

  • 11. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of labetalol in essential hypertension. Effects of long-term treatment in conditions of rest and stress].
    Rossi A; Ziacchi V; Lomanto B
    Minerva Cardioangiol; 1980 Sep; 28(9):637-44. PubMed ID: 7007921
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 16. [Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension].
    Cybulska I; Sznajderman M; Brym E; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(34):1309-11. PubMed ID: 7038638
    [No Abstract]   [Full Text] [Related]  

  • 17. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 19. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 20. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.